v3.24.3
Cash, Cash Equivalents and Investments - Narrative (Details) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Cash and Cash Equivalents [Line Items]      
Impairment for credit losses $ 0 $ 0  
Equity method investment other-than-temporary impairment     $ 100,000
Equity method investments 300,000   100,000
Available for sale debt securities allowance for credit loss 0   0
Cash      
Cash and Cash Equivalents [Line Items]      
Cash $ 257,200,000   $ 143,000,000.0